Ignite Creation Date:
2025-12-26 @ 4:02 PM
Ignite Modification Date:
2025-12-30 @ 5:42 AM
Study NCT ID:
NCT04476706
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2021-02-03
First Post:
2020-07-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Canakinumab MAP in COVID-19 Pneumonia With CRS
Sponsor:
Novartis Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CACZ885D2001M
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None